CHM chimeric therapeutics limited

Ann: CLTX CAR T PRESENTS POSITIVE INITIAL PHASE 1 CLINICAL DATA, page-5

  1. 318 Posts.
    lightbulb Created with Sketch. 229
    Very very positive! Especially for the initial low dose intertumoral which was completed in April. Dose level 2 cannot be too far away. If there are signs of efficacy in the first dose looking forward to seeing disease control at double the dose and the addition of intraventricular administration.

    Well done CHM. Webinar too! Good stuff..
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $6.217K 1.554M

Buyers (Bids)

No. Vol. Price($)
8 9210636 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 18629873 23
View Market Depth
Last trade - 11.35am 25/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.